Work

Updated results from a phase I trial of the histone deacetylase (HDAC) inhibitor MS-275 in patients with refractory solid tumors

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3026

Authors: L. Gore, S. N. Holden, M. Basche, S. K. S. Raj, I. Arnold, C. O'Bryant, S. Witta, B. Rohde, C. McCoy, S. G. Eckhardt

Institution: University of Colorado Denver

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2273216860

Cites:

Cited by: 23

Related to: 10